Results

1–10 of 86 results for Hereditary Retinal Disease & Genetics

Complications of Transvitreal Subretinal Injections for Gene Therapy Vectors in Inherited Retinal Diseases
Chloe TL Khoo, MD
Annual Meeting Talks
2023
Eighteen-Month Results From the Phase 1b-2 Study of Tinlarebant in Adolescent Subjects with Stargardt Disease
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2023
MCO-010 Optogenetic Therapy for Severe Vision Loss in Stargardt Disease: 6-Month Outcomes From the Phase 2 STARLIGHT Trial
Allen C Ho, MD FASRS
Annual Meeting Talks
2023
North Carolina Macular Dystrophy NCMD-MCDR1- Analysis of Our Entire Database a Model Disease of Noncoding Mutations
Kent W. Small, MD
Annual Meeting Talks
2023
Epidemiology of Inherited Retinal Diseases in the United States- IRIS Registry Intelligent Research In Sight Analysis
Ahmad Al-Moujahed, MD, PhD, MPH
Annual Meeting Talks
2023
Albinotic Fundus
KANWALJEET HARJOT MADAN, M.S. (Ophthalmology) Fellow in Vitreous & Retina
Retina Image Bank: Images of the Week
2025
Oral Gildeuretinol Acetate 14 mg Capsules Stalled Stargardt Disease Progression: Updates in the TEASE-3 Study
Michael Gorin, MD, PhD
Annual Meeting Talks
2024
One Year Follow-up in a Phase 1/2 Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Annual Meeting Talks
2024
BCVA Analysis of Low- or High-Dose MCO-010 Optogenetic Therapy for Retinitis Pigmentosa: FIRST TIME 100-Week TOPLINE Results From a Phase 2b/3 Clinical Trial (RESTORE)
Michael A. Singer, MD
Annual Meeting Talks
2024
Preclinical Evaluation of BGTF-027 (AAV.7m8-L-opsin), a Novel Intravitreal Gene Therapy for the Treatment of Blue Cone Monochromacy
Szilárd Kiss, MD
Annual Meeting Talks
2024